Pfizer and 3 Other Stocks in Focus After Goldman Sachs and Others Buy and Sell Stakes

Synopsis: Stocks including ADF Foods, Pfizer, and two others saw notable price gains alongside significant institutional activity, including bulk deals by SBI, Goldman Sachs, Nippon India, and SSPL Securities, highlighting continued investor interest. Markets witnessed a series of notable bulk deals across multiple sectors, signalling continued institutional participation and strategic portfolio reshuffling. Several small-cap stock […] The post Pfizer and 3 Other Stocks in Focus After Goldman Sachs and Others Buy and Sell Stakes appeared first on Trade Brains.

Apr 27, 2026 - 12:30
 0
Pfizer and 3 Other Stocks in Focus After Goldman Sachs and Others Buy and Sell Stakes

Synopsis: Stocks including ADF Foods, Pfizer, and two others saw notable price gains alongside significant institutional activity, including bulk deals by SBI, Goldman Sachs, Nippon India, and SSPL Securities, highlighting continued investor interest.

Markets witnessed a series of notable bulk deals across multiple sectors, signalling continued institutional participation and strategic portfolio reshuffling. Several small-cap stock counters saw heightened activity alongside positive price movement during the session. 

The transactions highlight sustained investor interest, with both buying and selling activity from prominent domestic and global funds. This comes amid improving sentiment and selective accumulation in fundamentally strong businesses.

ADF Foods Ltd

ADF Foods is an Indian packaged food company known for its ready-to-eat meals, pickles, sauces, and frozen foods. It operates popular brands like Ashoka and Soul, with a strong presence in export markets such as the US, UK, and the Middle East. 

With a market capitalisation of Rs. 2,977 cr, the shares of ADF Foods Ltd were trading at Rs. 271 per share, increasing by over 4% in today’s market session, up from its previous close of Rs. 260 per share. SBI Funds Management purchased 9 lakh shares at a price of Rs. 260 each. Total value of the deal is approximately Rs. 23.4 crore.

Pfizer Ltd

Pfizer Ltd is the Indian arm of global pharmaceutical giant Pfizer Inc, engaged in manufacturing and marketing a wide range of medicines across therapeutic areas like vaccines, cardiology, and anti-infectives. The company benefits from strong parentage, a trusted brand, and a portfolio of established products.

With a market capitalisation of Rs. 21,821 cr, the shares of Pfizer Ltd were trading at Rs. 4769.95 per share, increasing by over 2% in today’s market session, up from its previous close of Rs. 4,734.55 per share. Goldman Sachs Funds – Goldman Sachs India Equity Portfolio sold 4.26 lakh shares, while Prudential ICICI Mutual Fund (Discovery Fund) purchased 4 lakh shares at Rs. 4,700 per share. 

Orient Electric Ltd

Orient Electric is a consumer electrical products company offering fans, lighting, switches, and home appliances. Part of the CK Birla Group, it has a strong distribution network across India and is known for its innovation in fans and energy-efficient lighting. 

With a market capitalisation of Rs. 4,141 cr, the shares of Orient Electric Ltd were trading at Rs. 194.10 per share, increasing by over 5% in today’s market session, up from its previous close of Rs. 184.30 per share. Nippon India Mutual Fund acquired 12.85 lakh shares at a price of Rs. 185.96 per share. Total value of the deal is approximately Rs. 23.9 crore.

Yatra Online Ltd

Yatra Online is one of India’s leading online travel agencies, providing services such as flight and hotel bookings, holiday packages, and corporate travel management. It has a strong presence in the B2B segment through its corporate travel solutions, alongside its consumer-facing platform, and continues to benefit from the recovery and growth of India’s travel and tourism sector.

With a market capitalisation of Rs. 1,791 cr, the shares of Yatra Online Ltd were trading at Rs. 114.19 per share, increasing 2% in today’s market session, up from its previous close of Rs. 112.51 per share. SSPL Securities sold 10 lakh shares at a price of Rs. 112.6 per share, amounting to a total transaction value of Rs. 11.26 crore.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Pfizer and 3 Other Stocks in Focus After Goldman Sachs and Others Buy and Sell Stakes appeared first on Trade Brains.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow